2 FTSE 100 and FTSE 250 shares I’d consider buying to hold for 5 years!

I believe these FTSE 350 shares could help supercharge my returns over the next several years. Here’s why I’d buy them for my Stocks and Shares ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m searching for the best FTSE 100 and FTSE 250 shares to buy and hold to the end of the decade. Here are two on my watchlist.

Spire Healthcare Group

The poor state of the National Health Service (NHS) makes Spire Healthcare Group (LSE:SPI) an attractive investment today. Demand for private healthcare is likely to continue rising as patients seek to avoid long waiting lists.

Fresh Office for National Statistics research shows that almost 10m people are either waiting for a hospital appointment or to begin receiving NHS treatment. This backlog will likely take years to cut substantially, a challenge made all the more difficult by the growing healthcare needs of an ageing population.

It’s why I expect demand for Spire’s services from both self-pay patients and those using private medical insurance to keep soaring. Private revenues jumped 9.5% year on year in 2023, to £959.7m which, in turn, pushed operating profit almost a third higher, to £126.2m.

Spire can also expect further business from the NHS to help cut those massive waiting lists. NHS-related revenues leapt 15.5% in 2023, to £341.1m. And Spire has advised that “there could be increased commissioning” further down the line.

Reflecting this bright outlook, City analysts expect annual earnings growth here to average 34% through to 2026. This leaves the FTSE 250 firm trading on a forward price-to-earnings growth (PEG) ratio of 0.8.

Any reading below 1 indicates that a stock is undervalued. Despite the threat of potential staffing shortages, I’m considering adding more Spire shares to my portfolio.

Antofagasta

I also think getting exposure to copper could be a good idea today. Prices of the essential metal just struck 14-month highs of $9,300 a tonne on mounting supply risks. And bets of further rises are growing on hopes of recovering Chinese demand.

Analysts at Citi, for instance, expect copper values to hit $12,000 within the next two years.

Purchasing a copper-backed exchange-traded fund (ETF) could allow me to exploit any further price rises. But I’d rather buy shares in a dividend-paying mining stock. This strategy would also provide me with an income.

Antofagasta (LSE:ANTO) is one such stock to consider buying today. For this year the Chile-focused miner carries a dividend yield of 1.2%, a figure that rises steadily through to 2026.

While some other copper stocks offer larger yields, Antofagasta has one large advantage: a string of world-class assets that could help it deliver sector-beating returns. This includes the Los Pelambres mine where it is steadily ramping up production.

The FTSE 100 firm now trades on a price-to-earnings (P/E) ratio of 35.6 times. A high figure such as this could cause a share price correction if news suddenly worsens. Yet on balance, I still believe it’s a top stock to consider owning for the next several years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Spire Healthcare Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

No savings? I’d use the Warren Buffett method to target big passive income

This Fool looks at a couple of key elements of Warren Buffett's investing philosophy that he thinks can help him…

Read more »

Investing Articles

This FTSE 100 hidden gem is quietly taking things to the next level

After making it to the FTSE 100 index last year, Howden Joinery Group looks to be setting its sights on…

Read more »

Investing Articles

A £20k Stocks and Shares ISA put into a FTSE 250 tracker 10 years ago could be worth this much now

The idea of a Stocks and Shares ISA can scare a lot of people away. But here's a way to…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

What next for the Lloyds share price, after a 25% climb in 2024?

First-half results didn't do much to help the Lloyds Bank share price. What might the rest of the year and…

Read more »

Investing Articles

I’ve got my eye on this FTSE 250 company

The FTSE 250's full of opportunities for investors willing to do the search legwork, and I think I've found one…

Read more »

Investing Articles

This FTSE 250 stock has smashed Nvidia shares in 2024. Is it still worth me buying?

Flying under most investors' radars, this FTSE 250 stock has even outperformed the US chip maker year-to-date. Where will its…

Read more »

Investing Articles

£11k stashed away? I’d use it to target a £1,173 monthly passive income starting now

Harvey Jones reckons dividend-paying FTSE 100 shares are a great way to build a long-term passive income with minimal effort.

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

10% dividend increase! Is IMI one of the best stocks to buy in the FTSE 100 index?

To me, this firm's multi-year record of well-balanced progress makes the FTSE 100 stock one of the most attractive in…

Read more »